March 2024
-
03.05.2024
February 2024
-
02.29.2024
-
02.29.2024
-
02.26.2024
-
02.19.2024
Prescription Medicines Medicines European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
-
02.15.2024
-
02.05.2024
January 2024
-
01.30.2024
Corporate Financial Finance Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
-
01.26.2024
-
01.10.2024
-
01.09.2024
-
01.08.2024